Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register

OBJECTIVES: Anticarbamylated protein (anti-CarP) antibodies are a novel family of autoantibodies recently identified in patients with inflammatory arthritis. The aim of this study was to investigate their association with long-term outcomes of disability and disease activity over 20 years’ follow-up...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphreys, Jennifer H, Verheul, Marije K, Barton, Anne, MacGregor, Alexander J, Lunt, Mark, Toes, Rene EM, Symmons, Deborah PM, Trouw, Leendert A, Verstappen, Suzanne MM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893092/
https://www.ncbi.nlm.nih.gov/pubmed/26443608
http://dx.doi.org/10.1136/annrheumdis-2015-207326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893092/
https://www.ncbi.nlm.nih.gov/pubmed/26443608
http://dx.doi.org/10.1136/annrheumdis-2015-207326

Ejemplares similares